Coffee ☕ on Nostr: Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their ...
Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the drugmaker’s entire research budget for the past three decades, undercutting a key argument for their unusually high prices.
#HiveNews | #Press | #PlebChain
Published at
2024-09-23 16:49:47Event JSON
{
"id": "00ba83972645fa54c554617b8c303514587596d702f818811be30a6708069484",
"pubkey": "f647c9568d09596e323fdd0144b8e2f35aaf5daa43f9eb59b502e99d90f43673",
"created_at": 1727110187,
"kind": 1,
"tags": [
[
"t",
"HiveNews"
],
[
"t",
"hivenews"
],
[
"t",
"Press"
],
[
"t",
"press"
],
[
"t",
"PlebChain"
],
[
"t",
"plebchain"
]
],
"content": "Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the drugmaker’s entire research budget for the past three decades, undercutting a key argument for their unusually high prices.\n\n#HiveNews | #Press | #PlebChain ",
"sig": "9c9a2f78d1510a6b07f46dd535b9e6e91c53a51385a52159c03d43654f5bbdddb0140eb93342e1f581dde1df249e31eeb9a3dcb061c1b922901c21ec4cfb6fac"
}
